{"text": ["Novartis'", "Gilenya", "Approved", "in", "EU", "for", "Expanded", "Population"], "created_at": "2018-11-30 22:07:07"}
{"text": ["Novartis'", "Gilenya", "Approved", "in", "EU", "for", "Expanded", "Population"], "created_at": "2018-11-30 22:07:07"}
{"text": ["Pfizer", "Stock", "Edges", "Into", "Buy", "Zone", "On", "AbbVie", "Deal", "For", "Humira", "Biosimilar"], "created_at": "2018-11-30 21:16:14"}
{"text": ["This", "Biotech", "Stock", "Could", "Launch", "Its", "First", "CRISPR", "Drug", "In", "2022"], "created_at": "2018-11-30 21:14:35"}
{"text": ["Novartis'", "Gilenya", "Approved", "in", "EU", "for", "Expanded", "Population"], "created_at": "2018-11-30 20:19:08"}
{"text": ["Novartis", "CEO", "Has", "One", "New", "Breakthrough", "Drug:", "It", "Costs", "$4", "Million"], "created_at": "2018-11-30 20:12:03"}
